VASODILATORY SHOCK
Clinical trials for VASODILATORY SHOCK explained in plain language.
Never miss a new study
Get alerted when new VASODILATORY SHOCK trials appear
Sign up with your email to follow new studies for VASODILATORY SHOCK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a targeted drug beat standard care for shock in liver patients?
Disease control OngoingThis study tests whether a drug called Angiotensin II can raise blood pressure more effectively than standard medications in people with liver cirrhosis who have septic shock. Researchers will measure how well the heart and blood vessels work together over 24 hours. The trial inv…
Matched conditions: VASODILATORY SHOCK
Phase: EARLY_PHASE1 • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for children in shock: experimental drug targets low blood pressure
Disease control ENROLLING_BY_INVITATIONThis study tests a drug called Angiotensin II in children under 18 with life-threatening low blood pressure (vasodilatory shock) that hasn't improved with fluids or standard medicines. The goal is to see if the drug can safely raise blood pressure and reduce the need for other st…
Matched conditions: VASODILATORY SHOCK
Phase: PHASE4 • Sponsor: Todd Sweberg • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC